This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Accenture: Analysts' Upgrades, Downgrades

Stocks in this article: ACN ADM COP


Accenture (ACN) was upgraded to Outperform at Wells Fargo. Visibility is improving, and business fundamentals appear to have reached an inflection point.

Archer-Daniels Midland (ADM) was downgraded to Market Perform at BMO Capital. Valuation call, based on a $36 price target.

Beacon Roofing (BECN) was downgraded from Outperform to Neutral at Robert Baird. $16 price target. Shingle pricing has turned negative.

ConocoPhillips (COP) was downgraded to Underweight at Morgan Stanley. Valuation call, based on a $56 price target.

Deere (DE) was downgraded to Market Perform at Wells Fargo. Company is not likely to raise guidance above current consensus expectations.

Amdocs (DOX) was started with a Hold rating at ThinkEquity. $30 price target. Future growth will most likely be driven by acquisitions.

Idacorp (IDA) was upgraded from Hold to Buy at Keybanc. $38.50 price target. Two tax deductions will benefit equity value.

Limited Brands (LTD) was downgraded to Sell at Goldman Sachs. $24 price target. Company faces earnings headwinds in 2011.

Norfolk Southern (NSC) was downgraded to Market Perform at Wells Fargo. Valuation call, as coal demand could wane.

Rubicon Technology (RBCN) was initiated with a Sell rating at Merriman, Curhan Ford. Supply has caught up to demand in LCD lighting.

The Hanover Insurance Group (THG) was downgraded to Equal Weight from Overweight at Barclays. Less earnings power and reduced ROE improvement, Barclays said. Price target cut to $46 from $49.

Walgreen (WAG) was upgraded from Equal-Weight to Overweight at Morgan Stanley. $40 price target. Company faces easy comparisons for the flu season.

Wright Medical (WMGI) was downgraded from Outperform to Neutral at Robert Baird. $17 price target. Company could struggle to achieve consensus earnings expectations.

Xilinx (XLNX) was downgraded from Neutral to Sell at Goldman Sachs. Estimates were also cut, as cyclical pressures could hurt earnings. $22 price target.


Accenture 2011 and 2012 estimates boosted to $3.03 and $3.46, respectively, at Credit Suisse. Banking on enterprise spend recovery, Credit Suisse said. Maintain Outperform rating and $55 price target.

Accenture estimates, target increased at Citigroup. Estimates were raised through 2012. Company had a good quarter and boosted guidance. Buy rating and new $53 price target.

Altera (ALTR) estimates, target reduced at Goldman. Estimates were cut through 2012, Goldman Sachs said. Company faces cyclical headwinds. Neutral rating and new $26 price target.

Covance (CVD) estimates, target boosted at Jefferies. Shares now seen reaching $54, according to Jefferies. Estimates also upped, given the new $2.2 billion contract from SNY. Buy rating.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,959.44 +154.64 0.87%
S&P 500 2,078.54 +7.89 0.38%
NASDAQ 4,781.4240 +16.0440 0.34%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs